Avani A. Pendse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Avani A. Pendse has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Chanjuan Shi
Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA
2 shared publications - Jadee Lee Neff
Department of Pathology, Duke University, Durham, North Carolina
2 shared publications - Jake G. Maule
Foundation Medicine, Morrisville, NC, 27560, USA
2 shared publications - James Ronald
Division of Vascular & Interventional Radiology, Department of Radiology, Duke University Hospital, Durham, NC 27710
2 shared publications - Kara Wegermann
Division of Gastroenterology, Department of Medicine, Duke University School of Medicine, Durham, NC
2 shared publications - Lisa M. Ho
Division of Abdominal Imaging, Department of Radiology, Duke University Medical Center, Durham, North Carolina
2 shared publications
Latest Publications
- 3 September 2025
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 164 (4) , 620-625
Vascular outflow obstruction changes and low prevalence of advanced fibrosis characterize the liver pathology in orthotopic heart transplant recipients
Objective: The number of orthotopic heart transplants (OHTs) performed each year continues to increase, as does the post-transplant survival rate. Little is known, however, about the morphologic changes in the liver after the patient has undergone an OHT. In this study, we retrospectively reviewed liver pathology in patients following OHT to comprehensively describe the histopathologic changes, particularly fibrosis. Methods: Three pathologists retrospectively reviewed liver biopsy samples in patients who had undergone OHT using a standardized checklist format. Results: In our cohort of 19 biopsies, the morphologic features of hepatic injury noted were in the form of vascular outflow obstruction (9 biopsies), portal inflammation (13 biopsies), cholestasis (8 biopsies), and steatosis/steatohepatitis (5 biopsies). There was no evidence of nodular regenerative hyperplasia. Five of 9 patients with vascular outflow obstruction had sinusoidal fibrosis. Of 8 patients with clinical suspicion of portal hypertension and cirrhosis, only 3 demonstrated advanced fibrosis. Conclusions: This is the first comprehensive account of histopathologic changes in the liver following OHT. This information will be beneficial for clinical decision-making when monitoring hepatic function and fibrosis in patients with OHT.
- 3 September 2025
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 164 (4) , 620-625
Vascular outflow obstruction changes and low prevalence of advanced fibrosis characterize the liver pathology in orthotopic heart transplant recipients
Objective: The number of orthotopic heart transplants (OHTs) performed each year continues to increase, as does the post-transplant survival rate. Little is known, however, about the morphologic changes in the liver after the patient has undergone an OHT. In this study, we retrospectively reviewed liver pathology in patients following OHT to comprehensively describe the histopathologic changes, particularly fibrosis. Methods: Three pathologists retrospectively reviewed liver biopsy samples in patients who had undergone OHT using a standardized checklist format. Results: In our cohort of 19 biopsies, the morphologic features of hepatic injury noted were in the form of vascular outflow obstruction (9 biopsies), portal inflammation (13 biopsies), cholestasis (8 biopsies), and steatosis/steatohepatitis (5 biopsies). There was no evidence of nodular regenerative hyperplasia. Five of 9 patients with vascular outflow obstruction had sinusoidal fibrosis. Of 8 patients with clinical suspicion of portal hypertension and cirrhosis, only 3 demonstrated advanced fibrosis. Conclusions: This is the first comprehensive account of histopathologic changes in the liver following OHT. This information will be beneficial for clinical decision-making when monitoring hepatic function and fibrosis in patients with OHT.
- 20 January 2025
- Published by Wiley in Histopathology
- Vol. 86 (6) , 1001-1009
Vascular flow alteration is a dominant pattern of liver pathology in patients with orthotopic lung transplants: a retrospective observational study
Aims: The number of orthotopic lung transplants (OLT) has skyrocketed since the 1960s, generating an ever‐increasing cohort of post‐OLT patients. Many challenges exist in the post‐OLT timeframe, including donor graft dysfunction, infection, malignancy, and immunosuppression‐related conditions. A rather elusive topic in the posttransplant setting remains the impact of the underlying disease process and donor lungs on other organ systems and the complications arising from the complex physiologic interactions. The liver represents a vital organ often impacted in many ways by the lung transplant procedure. Also, there is a higher likelihood of adverse outcomes in OLT recipients who have significant liver pathology. Yet little is known about the morphologic changes in liver after patients have received an OLT. In this study we retrospectively reviewed liver pathology cases obtained after the patient received an OLT.Methods and results: Histology was reviewed by three pathologists and evaluated with a standardized checklist format. In our cohort, we found morphologic features of hepatic injury in the form of vascular outflow obstruction, nodular regenerative hyperplasia, portal vessel changes, and steatosis/steatohepatitis, but there was a striking absence of advanced fibrosis in our cohort.Conclusion: Here we present the first comprehensive account of morphologic changes in livers of post‐OLT patients. We believe that this information will aid clinical decision‐making during monitoring of hepatic function and fibrosis in patients with OLT and other complex pulmonary diagnoses.
- 20 January 2025
- Published by Wiley in Histopathology
- Vol. 86 (6) , 1001-1009
Vascular flow alteration is a dominant pattern of liver pathology in patients with orthotopic lung transplants: a retrospective observational study
Aims: The number of orthotopic lung transplants (OLT) has skyrocketed since the 1960s, generating an ever‐increasing cohort of post‐OLT patients. Many challenges exist in the post‐OLT timeframe, including donor graft dysfunction, infection, malignancy, and immunosuppression‐related conditions. A rather elusive topic in the posttransplant setting remains the impact of the underlying disease process and donor lungs on other organ systems and the complications arising from the complex physiologic interactions. The liver represents a vital organ often impacted in many ways by the lung transplant procedure. Also, there is a higher likelihood of adverse outcomes in OLT recipients who have significant liver pathology. Yet little is known about the morphologic changes in liver after patients have received an OLT. In this study we retrospectively reviewed liver pathology cases obtained after the patient received an OLT.Methods and results: Histology was reviewed by three pathologists and evaluated with a standardized checklist format. In our cohort, we found morphologic features of hepatic injury in the form of vascular outflow obstruction, nodular regenerative hyperplasia, portal vessel changes, and steatosis/steatohepatitis, but there was a striking absence of advanced fibrosis in our cohort.Conclusion: Here we present the first comprehensive account of morphologic changes in livers of post‐OLT patients. We believe that this information will aid clinical decision‐making during monitoring of hepatic function and fibrosis in patients with OLT and other complex pulmonary diagnoses.
- 6 November 2024
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 74, 152391
T-cells are significantly reduced in the luminal gastrointestinal tract of patients with “complete” 22q11.2 deletion syndrome (DiGeorge syndrome): Utilization of chromogenic multiplex immunohistochemistry to define cellular populations
- 6 November 2024
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 74, 152391
T-cells are significantly reduced in the luminal gastrointestinal tract of patients with “complete” 22q11.2 deletion syndrome (DiGeorge syndrome): Utilization of chromogenic multiplex immunohistochemistry to define cellular populations
- 12 May 2023
- Published by Wiley in Diagnostic Cytopathology
- Vol. 51 (9) , 532-538
Cytomorphologic observations on the sclerosing variant of well‐differentiated pancreatic neuroendocrine tumors: Towards making specific diagnoses early
Background: The recently described sclerosing variant of pancreatic neuroendocrine tumor (spNET) shows prominent stromal fibrosis and decreased tumor cellularity in surgical pathology specimens. Although prognostic data are currently ambivalent, some studies have reported metastatic disease in small primary tumors, highlighting the need for early diagnosis. The aim of our study is to evaluate cytology specimens of spNET to determine its characteristic cytomorphologic features to expedite an early diagnosis.Methods: Twenty‐five cytology cases of spNET from 23 patients and 29 cytology cases of typical pancreatic neuroendocrine tumor (tpNET) from 29 patients diagnosed as such by surgical pathology evaluation were reviewed by two pathologists to assess adequacy of diagnostic material, cellularity and fibrosis. Radiographic findings and outcome data were collected.Results: With only 13 of 25 specimens deemed as diagnostic, spNET specimens were more often non‐diagnostic (p < .01) and less often hypercellular (p = .03) compared to tpNET counterparts. While at least focal fibrosis was observed in both groups, a subset of spNET cases showed small tumor cell groups entrapped in large fibrotic fragments. Importantly, spNETs tended to be metastatic at diagnosis (both regionally and distant), with a smaller average tumor size.Conclusion: The hypocellular nature of spNET cytology samples makes this variant difficult to diagnose. However, when adequate sample is available, a subset of spNET show characteristic cytomorphology that enables us to consider this specific diagnosis at first diagnostic sampling. It is crucial to diagnose this variant early given the propensity of small tumors with regional lymph node involvement and liver metastases.
- 12 May 2023
- Published by Wiley in Diagnostic Cytopathology
- Vol. 51 (9) , 532-538
Cytomorphologic observations on the sclerosing variant of well‐differentiated pancreatic neuroendocrine tumors: Towards making specific diagnoses early
Background: The recently described sclerosing variant of pancreatic neuroendocrine tumor (spNET) shows prominent stromal fibrosis and decreased tumor cellularity in surgical pathology specimens. Although prognostic data are currently ambivalent, some studies have reported metastatic disease in small primary tumors, highlighting the need for early diagnosis. The aim of our study is to evaluate cytology specimens of spNET to determine its characteristic cytomorphologic features to expedite an early diagnosis.Methods: Twenty‐five cytology cases of spNET from 23 patients and 29 cytology cases of typical pancreatic neuroendocrine tumor (tpNET) from 29 patients diagnosed as such by surgical pathology evaluation were reviewed by two pathologists to assess adequacy of diagnostic material, cellularity and fibrosis. Radiographic findings and outcome data were collected.Results: With only 13 of 25 specimens deemed as diagnostic, spNET specimens were more often non‐diagnostic (p < .01) and less often hypercellular (p = .03) compared to tpNET counterparts. While at least focal fibrosis was observed in both groups, a subset of spNET cases showed small tumor cell groups entrapped in large fibrotic fragments. Importantly, spNETs tended to be metastatic at diagnosis (both regionally and distant), with a smaller average tumor size.Conclusion: The hypocellular nature of spNET cytology samples makes this variant difficult to diagnose. However, when adequate sample is available, a subset of spNET show characteristic cytomorphology that enables us to consider this specific diagnosis at first diagnostic sampling. It is crucial to diagnose this variant early given the propensity of small tumors with regional lymph node involvement and liver metastases.
- 12 August 2021
- Published by Elsevier in Human Pathology
- Vol. 117, 1-8
Plasma cells are essentially absent in the luminal gastrointestinal tract of patients with “complete” 22q11.2 deletion syndrome (DiGeorge syndrome)
- 12 August 2021
- Published by Elsevier in Human Pathology
- Vol. 117, 1-8
Plasma cells are essentially absent in the luminal gastrointestinal tract of patients with “complete” 22q11.2 deletion syndrome (DiGeorge syndrome)
- 28 June 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (8) , 2632-2639
Comparison of clinical efficacy, subjective user experience, and safety for two different core biopsy needles, the Achieve® and Marquee®
Purpose To compare clinical efficacy, subjective radiologist preference, and complication rates for two different core biopsy needles, the Achieve® and Marquee®. Methods Retrospective review included consecutive patients who underwent 18 gauge non-targeted core liver biopsy, 30 with Achieve® (Merit Medical) and 30 with Marquee® (BD Bard) Pathologist (blinded to needle type) reviewed specimen total length, maximum width, and portal triad count. Sixteen radiologists subjectively rated (1 to 5(best)) each needle for cocking, firing, recoil, chamber exposure, handling, and overall. A medical records search of all (targeted and non-targeted) core liver biopsies 1/1/17–9/30/2020 compared rates of major (requiring transfusion and/or embolization) and minor (self-limited bleeding) hemorrhagic complications. Comparison between needle types was performed using t-test. Results For Achieve® and Marquee® needles, the respective mean (SD) for total length(mm) was 29.7(7.0) and 31.9(4.6), p = 0.1; max width(mm) was 0.78(0.1) and 0.85(0.1), p < 0.01; and number of portal triads was 15.3(5.3) and 17.3(5.3), p = 0.2. Radiologists subjectively preferred the Marquee® for several measures including cocking, chamber exposure, and overall (p < 0.02 for each), while the needles were rated similarly for firing, recoil, and handling. Review of 800 cases showed no difference in major (1.0% Achieve®, 1.9% Marquee®, p = 0.5) or minor (1.5% Achieve®, 0.5% Marquee®, p = 0.3) rates of hemorrhagic complications. Conclusion Liver biopsy specimens were significantly wider with Marquee® compared to Achieve®. Radiologists preferred the Marquee® for multiple tactile measures, while the major complication rate was not significantly different. While both needles have a similar side-notch design, the Marquee® needle demonstrates better sample quality and higher user preference, without compromising safety. Graphic abstract
- 28 June 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (8) , 2632-2639
Comparison of clinical efficacy, subjective user experience, and safety for two different core biopsy needles, the Achieve® and Marquee®
Purpose To compare clinical efficacy, subjective radiologist preference, and complication rates for two different core biopsy needles, the Achieve® and Marquee®. Methods Retrospective review included consecutive patients who underwent 18 gauge non-targeted core liver biopsy, 30 with Achieve® (Merit Medical) and 30 with Marquee® (BD Bard) Pathologist (blinded to needle type) reviewed specimen total length, maximum width, and portal triad count. Sixteen radiologists subjectively rated (1 to 5(best)) each needle for cocking, firing, recoil, chamber exposure, handling, and overall. A medical records search of all (targeted and non-targeted) core liver biopsies 1/1/17–9/30/2020 compared rates of major (requiring transfusion and/or embolization) and minor (self-limited bleeding) hemorrhagic complications. Comparison between needle types was performed using t-test. Results For Achieve® and Marquee® needles, the respective mean (SD) for total length(mm) was 29.7(7.0) and 31.9(4.6), p = 0.1; max width(mm) was 0.78(0.1) and 0.85(0.1), p < 0.01; and number of portal triads was 15.3(5.3) and 17.3(5.3), p = 0.2. Radiologists subjectively preferred the Marquee® for several measures including cocking, chamber exposure, and overall (p < 0.02 for each), while the needles were rated similarly for firing, recoil, and handling. Review of 800 cases showed no difference in major (1.0% Achieve®, 1.9% Marquee®, p = 0.5) or minor (1.5% Achieve®, 0.5% Marquee®, p = 0.3) rates of hemorrhagic complications. Conclusion Liver biopsy specimens were significantly wider with Marquee® compared to Achieve®. Radiologists preferred the Marquee® for multiple tactile measures, while the major complication rate was not significantly different. While both needles have a similar side-notch design, the Marquee® needle demonstrates better sample quality and higher user preference, without compromising safety. Graphic abstract
- Open Access
- 30 September 2020
- Published by Elsevier in Human Pathology: Case Reports
- Vol. 22, 200427
Unique presentation of a gastrointestinal stromal tumor, epithelioid type, with a dual copy loss of SDHA gene as a liver primary
- 30 September 2020
- Published by Elsevier in Human Pathology: Case Reports
- Vol. 22, 200427
Open AccessUnique presentation of a gastrointestinal stromal tumor, epithelioid type, with a dual copy loss of SDHA gene as a liver primary